Catalent Inc Contracts & Agreements

Form of Tax Indemnification Agreement (Filed With SEC on December 18, 2024)

Amendment to Registration Rights Agreement, dated as of April 17, 2024, by and among Catalent, Inc., Green Equity Investors VII, L.P., Green Equity Investors Side VII, L.P., LGP... (Filed With SEC on September 6, 2024)

Form Retention Agreement (Filed With SEC on May 29, 2024)

Offer letter, dated January 11, 2024, between Michael J. Hatzfeld, Jr. and Catalent, Inc (Filed With SEC on May 8, 2024)

Employment Agreement, dated August 28, 2023, between John Greisch and Catalent, Inc (Filed With SEC on May 8, 2024)

Termination Agreement, dated as of December 28, 2023, by and between Catalent Pharma Solutions GmbH and Manja Boerman (Filed With SEC on February 14, 2024)

Agreement and Plan of Merger, dated as of February 5, 2024, by and among the Company, Parent and Merger Sub (Filed With SEC on February 5, 2024)

Amendment No. 1 to Catalent, Inc. 2018 Omnibus Incentive Plan (Filed With SEC on January 26, 2024)

Form of Restricted Stock Unit Agreement for Non-Employee Directors (Filed With SEC on December 8, 2023)

Form of 2018 Omnibus Incentive Plan Restricted Stock Unit Agreement for Employees (Filed With SEC on December 8, 2023)

Form of 2018 Omnibus Incentive Plan Option Agreement for Employees (Filed With SEC on December 8, 2023)

Form of 2018 Omnibus Incentive Plan Performance Share Unit Agreement for Employees (Filed With SEC on December 8, 2023)

Form of Severance Agreement between US-based executive officers and Catalent Pharma Solutions, Inc (Filed With SEC on December 8, 2023)

Form of Severance Agreement between non-US-based executive officers and Catalent Pharma Solutions, Inc (Filed With SEC on December 8, 2023)

Offer letter, dated July 1, 2022, by and between Catalent, Inc. and Ricky Hopson (Filed With SEC on December 8, 2023)

Offer letter, dated May 1, 2023, by and between Catalent, Inc. and Ricky Hopson (Filed With SEC on December 8, 2023)

Amendment to Offer letter, dated August 14, 2023, by and between Catalent, Inc. and Ricky Hopson (Filed With SEC on December 8, 2023)

Employment Agreement, dated October 8, 2019, by and between Catalent Pharma Solutions GmbH and Manja Boerman (Filed With SEC on December 8, 2023)

Long Term International Assignment Letter, dated October 10, 2022, by and between Catalent Pharma Solutions LLC and Manja Boerman (Filed With SEC on December 8, 2023)

Amendment No. 10 to Amended and Restated Credit Agreement, dated as of November 22, 2023, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, JPMorgan... (Filed With SEC on November 27, 2023)

Amendment No. 9 to Amended and Restated Credit Agreement, dated as of September 27, 2023, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, JPMorgan... (Filed With SEC on September 28, 2023)

Cooperation Agreement, dated as of August 28, 2023, by and among Elliott Investment Management L.P., a Delaware limited partnership, Elliott Associates, L.P., a Delaware limited... (Filed With SEC on August 29, 2023)

Description of the Companys Common Stock, par value $0.01 per share (Filed With SEC on November 1, 2022)

Management Incentive Plan Summary for the fiscal year ending June 30, 2023 (Filed With SEC on November 1, 2022)

Offer Letter, dated July 27, 2022, by and between Catalent, Inc. and Thomas Castellano (Filed With SEC on November 1, 2022)

Catalent Pharma Solutions, Inc. Deferred Compensation Plan, as amended and restated effective October 1, 2022 (Filed With SEC on November 1, 2022)

Form of Restricted Stock Unit Agreement for U.S. Non-Employee Directors (fiscal 2023) (Filed With SEC on November 1, 2022)

Form of Restricted Stock Unit Agreement for non-U.S. Non-Employee Directors (fiscal 2023) (Filed With SEC on November 1, 2022)

Form of 2018 Omnibus Incentive Plan Restricted Stock Unit Agreement for U.S. Employees (fiscal 2023) (Filed With SEC on November 1, 2022)

Form of 2018 Omnibus Incentive Plan Restricted Stock Unit Agreement for non-U.S. Employees (fiscal 2023) (Filed With SEC on November 1, 2022)

Form of 2018 Omnibus Incentive Plan Option Agreement for U.S. Employees (fiscal 2023) (Filed With SEC on November 1, 2022)

Form of 2018 Omnibus Incentive Plan Option Agreement for non-U.S. Employees (fiscal 2023) (Filed With SEC on November 1, 2022)

Form of 2018 Omnibus Incentive Plan Performance Share Unit Agreement for U.S. Employees (fiscal 2023) (Filed With SEC on November 1, 2022)

Form of 2018 Omnibus Incentive Plan Performance Share Unit Agreement for Non-U.S. Employees (fiscal 2023) (Filed With SEC on November 1, 2022)

Offer letter, dated August 29, 2022, between Karen Santiago and the Company (Filed With SEC on September 19, 2022)

Offer letter, dated March 15, 2018, between Aristippos Gennadios and Catalent Pharma Solutions LLC (Filed With SEC on August 29, 2022)

Offer letter, dated July 7, 2022, between Steven Fasman and Catalent, Inc (Filed With SEC on August 29, 2022)

Offer letter, dated July 7, 2022, between Aristippos Gennadios and Catalent, Inc (Filed With SEC on August 29, 2022)

Employment Agreement, dated January 4, 2022, by and between Catalent, Inc. and Alessandro Maselli (Filed With SEC on January 5, 2022)

Amended and Restated Employment Agreement, dated January 4, 2022, by and between Catalent, Inc. and John R. Chiminski (Filed With SEC on January 5, 2022)

Form of Management Incentive Plan for the fiscal year ending June 30, 2022 (Filed With SEC on November 2, 2021)

Indenture, dated September 29, 2021, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, and Deutsche Bank Trust Company Americas, as trustee (Filed With SEC on September 29, 2021)

Membership Interest Purchase Agreement, dated August 29, 2021, by and among Catalent Pharma Solutions, Inc., Bettera Holdings, LLC, the members of Bettera Holdings, LLC, and... (Filed With SEC on August 30, 2021)

Offer letter, dated May 17, 2021, between Ricky Hopson and Catalent Pharma Solutions, Inc (Filed With SEC on May 20, 2021)

Offer letter, dated May 10, 2021, between Thomas Castellano and Catalent Pharma Solutions, Inc (Filed With SEC on May 11, 2021)

Indenture, dated February 22, 2021, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, and Deutsche Bank Trust Company Americas, as trustee (Filed With SEC on February 22, 2021)

Form of Management Incentive Plan for the fiscal year ending June 30, 2021 (Filed With SEC on November 3, 2020)

Offer letter, dated November 20, 2019, between Karen Flynn and Catalent Pharma Solutions Inc (Filed With SEC on August 31, 2020)

Form of Restricted Stock Unit Agreement for U.S. Non-Employee Directors (Filed With SEC on August 31, 2020)

Second Amendment to Employment Agreement, dated August 11, 2020, by and between Catalent, Inc. and John R. Chiminski (Filed With SEC on August 31, 2020)

Underwriting Agreement, dated June 10, 2020, between the Company and RBC Capital Markets, LLC (Filed With SEC on June 15, 2020)

Indenture, dated March 2, 2020, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, Deutsche Trustee Company Limited, as trustee, Deutsche Bank... (Filed With SEC on March 3, 2020)

Underwriting Agreement, dated February 3, 2020, among the Company, J.P. Morgan Securities LLC and UBS Securities LLC (Filed With SEC on February 6, 2020)

Stock Purchase Agreement, dated as of February 2, 2020, among Catalent Pharma Solutions, Inc., Orgenesis Inc. and GPP-II Masthercell, LLC (Filed With SEC on February 3, 2020)

Form of 2018 OIP Performance Share Unit Agreement for U.S. Employees (Filed With SEC on November 5, 2019)

Form of 2018 OIP Performance Share Unit Agreement for Non-U.S. Employees (Filed With SEC on November 5, 2019)

Form of Management Incentive Plan for the fiscal year ending June 30, 2020 (Filed With SEC on November 5, 2019)

First Amendment to Agreement and Plan of Merger, dated as of May 9, 2019, by and between Catalent Pharma Solutions, Inc. and Paragon Bioservices, Inc (Filed With SEC on August 27, 2019)

Description of the Companys Common Stock, par value $0.01 (Filed With SEC on August 27, 2019)

Offer letter, dated January 31, 2019, between Alessandro Maselli and Catalent Pharma Solutions (Filed With SEC on August 27, 2019)

Terms and Conditions of Employment Statement, dated February 1, 2018, between Alessandro Maselli and Catalent Pharma Solutions (Filed With SEC on August 27, 2019)

Offer letter, dated March 13, 2018, between Steven Fasman and Catalent Pharma Solutions Inc (Filed With SEC on August 27, 2019)

Rollover Agreement, dated as of May 9, 2019, between Pete Buzy and Catalent, Inc (Filed With SEC on August 27, 2019)

Offer letter, dated May 14, 2019, between Pete Buzy and Catalent Pharma Solutions Inc (Filed With SEC on August 27, 2019)

Option Grant Notice, dated May 17, 2019, to Pete Buzy (retention grant) (Filed With SEC on August 27, 2019)

Substitute Option Grant Notice and Agreement, dated May 17, 2019, between Pete Buzy and Catalent, Inc (Filed With SEC on August 27, 2019)

Summary of Management Incentive Plan for the fiscal year ended June 30, 2019 (Filed With SEC on August 27, 2019)

Indenture, dated June 27, 2019, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein, and Deutsche Bank Trust Company Americas, as trustee (Filed With SEC on June 27, 2019)

Stockholders Agreement, dated as of May 17, 2019, by and among Catalent, Inc., Green Equity Investors VII, L.P., Green Equity Investors Side VII, L.P., LGP Associates VII-A LLC... (Filed With SEC on May 22, 2019)

Registration Rights Agreement, dated as of May 17, 2019, by and among Catalent, Inc., Green Equity Investors VII, L.P., Green Equity Investors Side VII, L.P., LGP Associates VII-A... (Filed With SEC on May 22, 2019)

Form of 2018 OIP Restricted Stock Unit Agreement for U.S. Employees (Filed With SEC on May 7, 2019)

Form of 2018 OIP Restricted Stock Unit Agreement for Non-U.S. Employees (Filed With SEC on May 7, 2019)

Form of 2018 OIP Performance Share Unit Agreement for U.S. Employees (three-year performance period) (Filed With SEC on May 7, 2019)

Form of 2018 OIP Performance Share Unit Agreement for Non-U.S. Employees (three-year performance period) (Filed With SEC on May 7, 2019)

Form of 2018 OIP Option Agreement for U.S. Employees (Filed With SEC on May 7, 2019)

Form of 2018 OIP Option Agreement for Non-U.S. Employees (Filed With SEC on May 7, 2019)

Agreement and Plan of Merger, dated April 14, 2019, by and among Catalent Pharma Solutions, Inc., Paragon Bioservices, Inc., solely for purposes of 4.12 (solely with respect to... (Filed With SEC on April 17, 2019)

Equity Commitment and Investment Agreement, dated as of April 14, 2019, by and among Catalent, Inc. Green Equity Investors VII, L.P. and Green Equity Investors Side VII, L.P.... (Filed With SEC on April 17, 2019)

Catalent, Inc. 2018 Omnibus Incentive Plan with UK Sub-plan (Filed With SEC on February 5, 2019)

Form of Management Incentive Plan for the fiscal year ended June 30, 2018 (Filed With SEC on November 6, 2018)

Catalent, Inc. 2018 Omnibus Incentive Plan (Filed With SEC on November 6, 2018)

Catalent, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on November 6, 2018)

Form of Performance Restricted Stock Agreement for U.S. Employees (for the performance period July 1, 2016 through June 30, 2019) (Filed With SEC on August 28, 2018)

Form of Performance Restricted Stock Agreement for Non-U.S. Employees (for the performance period July 1, 2016 through June 30, 2019) (Filed With SEC on August 28, 2018)

Form of Performance Restricted Stock Agreement for U.S. Employees (for the performance period July 1, 2017 through June 30, 2020) (Filed With SEC on August 28, 2018)

Form of Performance Restricted Stock Agreement for Non-U.S. Employees (for the performance period July 1, 2017 through June 30, 2020) (Filed With SEC on August 28, 2018)

Form of the Performance Share Unit Agreement for U.S. Employees (for the performance period July 1, 2018 through June 30, 2021) (Filed With SEC on August 28, 2018)

Form of the Performance Share Unit Agreement for Non-U.S. Employees (for the performance period July 1, 2018 through June 30, 2021) (Filed With SEC on August 28, 2018)

Form of Performance Restricted Stock Agreement for U.S. Employees (for the performance period July 1, 2018 through June 30, 2021) (Filed With SEC on August 28, 2018)

Form of Performance Restricted Stock Agreement for Non-U.S. Employees (for the performance period July 1, 2018 through June 30, 2021) (Filed With SEC on August 28, 2018)

Offer letter, dated October 4, 2017, between Jonathan Arnold and Catalent Pharma Solutions GmbH (Filed With SEC on August 28, 2018)

Employment Agreement, dated October 4, 2017 between Jonathan Arnold and Catalent Pharma Solutions GmbH (Filed With SEC on August 28, 2018)

Form of Management Incentive Plan for the fiscal year ended June 30, 2018 (Filed With SEC on August 28, 2018)

Underwriting Agreement, dated July 24, 2018, between the Company, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and RBC Capital Markets, LLC, as representatives of the... (Filed With SEC on July 27, 2018)

Agreement and Plan of Merger, dated as of July 2, 2018, among Catalent Pharma Solutions, Inc., Catalent Boston, Inc., and Juniper Pharmaceuticals, Inc (Filed With SEC on July 3, 2018)

Offer letter, dated January 31, 2018 between Wetteny Joseph and Catalent Pharma Solutions, LLC (Filed With SEC on February 5, 2018)

Catalent Pharma Solutions, Inc. Deferred Compensation Plan as amended and restated effective January 1, 2016 (Filed With SEC on November 6, 2017)

Amendment to the Catalent Pharma Solutions, Inc. Deferred Compensation Plan dated October 16, 2017 (Filed With SEC on November 6, 2017)

Form of the Performance Share Unit Agreement for U.S. Employees for the performance period July 1, 2017 through June 30, 2020 (Filed With SEC on November 6, 2017)

Form of the Performance Share Unit Agreement for Non-U.S. Employees for the performance period July 1, 2017 through June 30, 2020 (Filed With SEC on November 6, 2017)

Indenture, dated October 18, 2017, by and among Catalent Pharma Solutions, Inc., the subsidiary guarantors named therein and Deutsche Bank Trust Company Americas, as trustee (Filed With SEC on October 18, 2017)

Amendment No. 3 to Amended and Restated Credit Agreement, dated as of October 18, 2017, by and among Catalent Pharma Solutions, Inc., PTS Intermediate Holdings LLC, Morgan Stanley... (Filed With SEC on October 18, 2017)

Underwriting Agreement, dated September 26, 2017, between the Company, Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and RBC Capital Markets, LLC, as representatives of the... (Filed With SEC on September 29, 2017)

Interest Purchase Agreement, dated September 18, 2017, by and among Catalent Pharma Solutions, Inc., Cook Pharmica LLC, Cook Group Incorporated, and, solely for purposes of... (Filed With SEC on September 19, 2017)

Catalent Pharma Solutions, Inc. Deferred Compensation Plan as amended and restated effective January 1, 2017 (Filed With SEC on August 28, 2017)

Form of Management Incentive Plan for the fiscal year ended June 30, 2017 (Filed With SEC on August 28, 2017)

Offer letter, dated May 2, 2011, between Barry Littlejohns and Catalent Pharma Solutions, Inc (Filed With SEC on August 28, 2017)

Form of Performance Share Unit Agreement for U.S. Employees for the performance period July 1, 2016 through June 30, 2019 (Filed With SEC on August 28, 2017)

Form of Performance Share Unit Agreement for Non-U.S. Employees for the performance period July 1, 2016 through June 30, 2019 (Filed With SEC on August 28, 2017)

Settlement Agreement, dated May 16, 2017, by and between Catalent Pharma Solutions Limited and Sharon Johnson (Filed With SEC on August 28, 2017)

AMENDMENT TO EMPLOYMENT AGREEMENT (John R. Chiminski) (Filed With SEC on August 28, 2017)

RESTRICTED STOCK GRANT NOTICE UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on August 28, 2017)

PERFORMANCE RESTRICTED STOCK GRANT NOTICE UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on August 28, 2017)

INDENTURE Dated as of December9, 2016 Among CATALENTPHARMA SOLUTIONS, INC. the Guarantors listed herein DEUTSCHE TRUSTEE COMPANY LIMITED as Trustee DEUTSCHE BANK AG,LONDON BRANCH... (Filed With SEC on December 12, 2016)

AMENDMENTNO. 2 TO AMENDED AND RESTATED CREDIT AGREEMENT (Filed With SEC on December 12, 2016)

Catalent, Inc. CommonStock, par value $0.01 per share Underwriting Agreement (Filed With SEC on September 9, 2016)

PERFORMANCE SHARE UNIT AGREEMENT UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Performance Period commencing on July 1, 2015 and ending on June 30, 2018) (Filed With SEC on August 29, 2016)

PERFORMANCE SHARE UNIT AGREEMENT FOR NON-U.S. PARTICIPANTS UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Performance Period commencing on July 1, 2015 and ending on June... (Filed With SEC on August 29, 2016)

Management Incentive Plan - FY2016 Summary Plan Description (Filed With SEC on August 29, 2016)

Catalent Pharma Solutions, Inc. Deferred Compensation Plan Amended and Restated Effective January 1, 2016 (Filed With SEC on August 29, 2016)

Catalent, Inc. CommonStock, par value $0.01 per share Underwriting Agreement (Filed With SEC on June 9, 2016)

PERFORMANCE SHARE UNIT GRANT NOTICE UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on September 2, 2015)

PERFORMANCE SHARE UNIT GRANT NOTICE FOR NON-U.S. PARTICIPANTS UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on September 2, 2015)

Management personnelAs at and effective from:18thApril 2011Name:Sharon JohnsonJob Title:SVP, Global QualityThe Principal Place of Employment:Swindon, WiltsContinuous service... (Filed With SEC on September 2, 2015)

Sharon JohnsonDate (Filed With SEC on September 2, 2015)

Catalent, Inc. CommonStock, par value $0.01 per share Underwriting Agreement (Filed With SEC on June 1, 2015)

Catalent, Inc. CommonStock, par value $0.01 per share Underwriting Agreement (Filed With SEC on March 2, 2015)

AMENDMENT NO. 1 TO THE CREDIT AGREEMENT (Filed With SEC on December 2, 2014)

PERFORMANCE SHARE UNIT GRANT NOTICE UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on November 14, 2014)

PERFORMANCE SHARE UNIT GRANT NOTICE FOR NON-U.S. PARTICIPANTS UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on November 14, 2014)

EMPLOYMENT AGREEMENT (John R. Chiminski) (Filed With SEC on October 24, 2014)

STOCKHOLDERS AGREEMENT DATED AS OF AUGUST 5, 2014 AMONG CATALENT, INC. AND BLACKSTONE HEALTHCARE PARTNERS L.L.C. Table of Contents (Filed With SEC on August 5, 2014)

REGISTRATION RIGHTS AGREEMENT by and among CATALENT, INC. and the other parties hereto Dated as of August 5, 2014 TABLE OF CONTENTS (Filed With SEC on August 5, 2014)

CATALENT, INC. 2014OMNIBUS INCENTIVE PLAN (Filed With SEC on August 5, 2014)

OPTION GRANT NOTICE UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on August 5, 2014)

RESTRICTED STOCK UNIT GRANT NOTICE UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on August 5, 2014)

OPTION GRANT NOTICE FOR NON-U.S. PARTICIPANTS UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on August 5, 2014)

RESTRICTED STOCK UNIT GRANT NOTICE FOR NON-U.S. PARTICIPANTS UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on August 5, 2014)

REGISTRATION RIGHTS AGREEMENT by and among CATALENT, INC. and the other parties hereto Dated as of [ ], 2014 TABLE OF CONTENTS (Filed With SEC on May 30, 2014)

Catalent, Inc. CommonStock, par value $0.01 per share Underwriting Agreement (Filed With SEC on May 5, 2014)

CATALENT, INC. 2014OMNIBUS INCENTIVE PLAN (Filed With SEC on May 5, 2014)

OPTION GRANT NOTICE UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on May 5, 2014)

RESTRICTED STOCK UNIT GRANT NOTICE UNDER THE CATALENT, INC. 2014 OMNIBUS INCENTIVE PLAN (Filed With SEC on May 5, 2014)

STOCKHOLDERS AGREEMENT DATED AS OF [ ], 2014 AMONG CATALENT, INC. BLACKSTONE HEALTHCARE PARTNERS L.L.C. AND PHOENIX CHARTERLLC Table of Contents (Filed With SEC on May 5, 2014)

AMENDMENT NO.2 TO THE 2007 PTS HOLDINGS CORP. STOCK INCENTIVE PLAN (Filed With SEC on February 28, 2014)

Category

Industry

Companies

Contracts

Catalent Inc Contracts & Agreements